title: Molecular Docking Studies of Phytocompounds from the Phyllanthus Species as Potential Chronic Pain Modulators.
abstract: The study of inflammatory pain has been one of the most rapidly advancing and expanding areas of pain research in recent years. Studies from our lab have demonstrated the chronic pain-modulating potential of the Phyllanthus species and their probable interaction with various inflammatory mediators involving enzymes like COX-2 and PGE synthase, cytokines like TNF-alpha and IL-1 beta, and with the NMDA receptor. Inflammatory mediators which play a crucial role in chronic inflammatory hyperalgesia and its subsequent modulation were selected for their interactions with 86 structurally diverse phytoconstituents identified from the Phyllanthus species. The docking analysis of the target proteins with the phytochemical ligands was performed using VLifeMDS software. The docking scores and analysis of the interactions of the phytocompounds with target proteins suggest that important molecules like lupeol, phyllanthin, hypopyllanthin, corilagin, epicatechin, and most of the other compounds have the ability to bind to multiple targets involved in inflammatory hyperalgesia. Our study strongly suggests that the findings of the present study could be exploited in the future for designing ligands in order to obtain novel molecules for the treatment and management of chronic pain.
authors.affiliation: Department of Pharmacology and Pharmacognosy, Government College of Pharmacy, Karad, District Satara, 415124 Maharashtra, India; Department of Pharmacology, Rajarambapu College of Pharmacy, Kasegaon, District-Sangli, 415404 Maharashtra, India.
authors.forename: Atul R
authors.initials: AR
authors.lastname: Chopade
authors.affiliation: Department of Pharmacology and Pharmacognosy, Government College of Pharmacy, Karad, District Satara, 415124 Maharashtra, India; Department of Pharmacology, Rajarambapu College of Pharmacy, Kasegaon, District-Sangli, 415404 Maharashtra, India.
authors.forename: Fahim J
authors.initials: FJ
authors.lastname: Sayyad
authors.affiliation: Department of Pharmaceutical chemistry, Government College of Pharmacy, Karad, District Satara, 415124 Maharashtra, India.
authors.forename: Yogesh V
authors.initials: YV
authors.lastname: Pore
keywords: Docking; InflammatoryPain; Phyllanthus; Phytochemical ligands
references.citation: J Clin Invest. 2008 Nov;118(11):3537-45
references.pmid: 18982160
references.citation: EMBO J. 2009 Dec 16;28(24):3910-20
references.pmid: 19910922
references.citation: Trends Neurosci. 2002 Jun;25(6):319-25
references.pmid: 12086751
references.citation: Pain. 1995 Jan;60(1):91-102
references.pmid: 7715946
references.citation: Handb Clin Neurol. 2006;81:103-25
references.pmid: 18808831
references.citation: J Ethnopharmacol. 2013 Mar 7;146(1):318-23
references.pmid: 23333746
references.citation: Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19749-53
references.pmid: 17179045
references.citation: Curr Genomics. 2010 Mar;11(1):70-6
references.pmid: 20808527
references.citation: J Pain. 2009 Dec;10(12):1231-41
references.pmid: 19592308
references.citation: Curr Opin Pharmacol. 2007 Jun;7(3):344-51
references.pmid: 17475558
references.citation: Biochimie. 2010 Jun;92 (6):651-9
references.pmid: 20159030
references.citation: Eur J Pain. 2006 Aug;10(6):537-49
references.pmid: 16199187
references.citation: Life Sci. 2005 Dec 22;78(5):431-41
references.pmid: 16198377
references.citation: Pain. 2003 Aug;104(3):567-77
references.pmid: 12927629
references.citation: J Neurosci. 2005 Nov 30;25(48):11107-16
references.pmid: 16319310
references.citation: Med Res Rev. 1998 Jul;18(4):225-58
references.pmid: 9664291
references.citation: Cent Nerv Syst Agents Med Chem. 2013 Mar;13(1):30-5
references.pmid: 23092407
references.citation: Handb Clin Neurol. 2014;119:577-84
references.pmid: 24365321
references.citation: Mol Aspects Med. 2006 Feb;27(1):1-93
references.pmid: 16105678
references.citation: J Ethnopharmacol. 2011 Nov 18;138(2):286-313
references.pmid: 21982793
references.citation: Pharmazie. 2000 Dec;55(12):945-6
references.pmid: 11189874
references.citation: Eur J Clin Pharmacol. 2010 May;66(5):429-44
references.pmid: 20155257
references.citation: Nat Neurosci. 2001 Feb;4(2):164-9
references.pmid: 11175877
references.citation: J Pain Res. 2011;4:301-8
references.pmid: 22003303
references.citation: ScientificWorldJournal. 2014 Feb 03;2014:839172
references.pmid: 24672382
references.citation: J Leukoc Biol. 2001 Dec;70(6):849-60
references.pmid: 11739546
references.citation: Curr Pharm Des. 2006;12 (8):943-54
references.pmid: 16533161
references.citation: Bioorg Med Chem Lett. 2010 Dec 1;20(23):7159-63
references.pmid: 20709553
references.citation: J Pharm Pharmacol. 2006 Dec;58(12):1559-70
references.pmid: 17331318
references.citation: Eur J Pharmacol. 2003 Oct 8;478(2-3):145-53
references.pmid: 14575799
references.citation: J Mol Biol. 2005 May 20;348(5):1163-76
references.pmid: 15854652
references.citation: Eur J Pharmacol. 2004 Mar 8;487(1-3):93-103
references.pmid: 15033380
references.citation: J Pharmacol Exp Ther. 2006 Dec;319(3):1043-50
references.pmid: 16973887
references.citation: J Clin Invest. 2010 Nov;120(11):3753-9
references.pmid: 21041957
references.citation: Eur J Pharmacol. 2006 Sep 28;546(1-3):182-8
references.pmid: 16925995
references.citation: Science. 2005 Nov 11;310(5750):1022-5
references.pmid: 16284179
references.citation: Inflamm Allergy Drug Targets. 2013 Oct;12(5):349-61
references.pmid: 23876224
references.citation: Inflamm Allergy Drug Targets. 2010 Sep;9(4):263-85
references.pmid: 20887269
references.citation: Muscle Nerve. 2001 Jan;24(1):37-46
references.pmid: 11150964